IMMUNOMEDICS, INC.

US Patent 11116846 Antibody-drug conjugates and uses thereof

US Patent RE48751 Immunoconjugates with an intracellularly-cleavable linkage

US Patent 11077201 Immunoconjugates with an intracellularly-cleavable linkage

US Patent 7109304 Humanized anti-CD19 antibodies

US Patent 7138103 Use of bi-specific antibodies for pre-targeting diagnosis and therapy

US Patent 7147856 Stable radioiodine conjugates and methods of their synthesis

US Patent 7151164 Anti-CD20 antibodies and fusion proteins thereof and methods of use

US Patent 7172751 D-amino acid peptides

US Patent 7201890 Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy

US Patent 7230084 Therapeutic using a bispecific antibody

US Patent 7230085 Anti-DOTA antibody

US Patent 7238785 RS7 antibodies

US Patent 7238786 Monoclonal antibody cPAM4

US Patent 7259249 Method for preparing conjugates of proteins and chelating agents

US Patent 7282567 Monoclonal antibody hPAM4

US Patent 7300644 Targeted combination immunotherapy

US Patent 7300655 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof

US Patent 7312318 Internalizing anti-CD74 antibodies and methods of use

US Patent 7323168 Immunotherapy for chronic myelocytic leukemia

US Patent 7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications

US Patent 7354587 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines

US Patent 11180559 Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies

US Patent 7405320 Therapeutic and diagnostic conjugates for use with multispecific antibodies

US Patent 7413736 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications

US Patent 7414121 Chimeric, human and humanized anti-CSAp monoclonal antibodies

US Patent 7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies

US Patent 7435803 Anti-CD20 antibodies and fusion proteins thereof and methods of use

US Patent 7462352 Methods of treatng B-cell diseases using humanized anti-CD19 antibodies

US Patent 7470429 Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug

US Patent 7501498 Alpha-fetoprotein Immu31 antibodies and fusion proteins

US Patent 7514066 Targeted combination immunotherapy of cancer and infectious diseases

US Patent 7517964 RS7 antibodies

US Patent 7521416 D-amino acid peptides

US Patent 7521531 Methods for the purification of stable radioiodine conjugates

US Patent 7531327 Methods and compositions for increasing longevity and protein yield from a cell culture

US Patent 7534427 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins

US Patent 7534431 Methods and compositions for administering therapeutic and diagnostic agents

US Patent 7537930 Mammalian cell lines for increasing longevity and protein yield from a cell culture

US Patent 7541440 Chimeric, human and humanized anti-granulocyte antibodies and methods of use

US Patent 7544487 Fusion proteins containing recombinant cytotoxic RNAses

US Patent 7553953 Chimeric, human and humanized anti-CSAp monoclonal antibodies

US Patent 7560110 Production and use of novel peptide-based agents with bispecific antibodies

US Patent 7563433 Methods and compositions for F-18 labeling of proteins, peptides and other molecules

US Patent 7563439 Production and use of novel peptide-based agents for use with bi-specific antibodies

US Patent 7585491 Immunoconjugates with an intracellularly-cleavable linkage

US Patent 7591994 Camptothecin-binding moiety conjugates

US Patent 7597876 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

US Patent 7608425 Methods for protein expression in mammalian cells in serum-free medium

US Patent 7612180 Humanized L243 antibodies

US Patent 7641891 Chimeric, human and humanized anti-CSAp monoclonal antibodies

US Patent 7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells

US Patent 7662378 Antibody therapy

US Patent 7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies

US Patent 7670804 Chimeric, human and humanized anti-CSAP monoclonal antibodies

US Patent 7772373 Internalizing anti-CD74 antibodies and methods of use

US Patent 7776311 D-amino acid peptides

US Patent 7785880 Mammalian cell lines for increasing longevity and protein yield from cell culture

US Patent 7803372 Antibody therapy

US Patent 7811570 Method of affecting a function of or ablating a non-malignant cell

US Patent 7820164 Chimeric, human and humanized anti-CSAP monoclonal antibodies

US Patent 7829064 Anti-CD74 immunoconjugates and methods

US Patent 7833528 Use of multispecific, non-covalent complexes for targeted delivery of therapeutics

US Patent 7837995 Immunotherapy of B-cell malignancies using anti-CD22 antibodies

US Patent 7842279 F-18 peptides for pre targeted positron emission tomography imaging

US Patent 7892547 Methods and compositions for administering therapeutic and diagnostic agents

US Patent 7902338 Anti-CD19 antibodies

US Patent 7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies

US Patent 7914787 Production and use of novel peptide-based agents with bispecific antibodies

US Patent 7919087 Internalizing anti-CD74 antibodies and methods of use

US Patent 7919090 Antibody therapy

US Patent 7919273 Structural variants of antibodies for improved therapeutic characteristics

US Patent 7931890 Targeted combination immunotherapy of cancer and infectious diseases

US Patent 7931903 Internalizing anti-CD74 antibodies and methods of use

US Patent 7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies

US Patent 7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies

US Patent 7951369 Chimeric, human and humanized anti-granulocyte antibodies and methods of use

US Patent 7951921 Multivalent carriers of bi-specific antibodies

US Patent 7993626 Methods and compositions for F-18 labeling of proteins, peptides and other molecules

US Patent 7999083 Immunoconjugates with an intracellularly-cleavable linkage